ClinicalTrials.gg
Active, not recruitingNCT06032299Updated Mar 10, 2026

Dual Implant Versus Single Implant Distal End of Femur

An interventional study of Single Distal Femur Implant and Dual Distal Femur Implant in Femur Fracture, sponsored by Mayo Clinic. Active, not recruiting at 1 site in United States. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2026-03-10.

Sponsored by Mayo Clinic · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 46 studies in Femoral Fractures with a site in United States — 6 open to participants now, 7 under way, none of them phase 3. Femoral Fractures · United States.

Planned enrollment
13th of 29
60 · median 55
Started
2024
with 3 others
No phase
21 of 46
3 open now
Registered
42nd of 46
by date

Among the 46 studies in Femoral Fractures with a site in United States, this one is the 13th largest by planned enrollment of the 29 interventional ones that give a count, is one of 4 that started in 2024, is one of 21 with no phase, and was the 42nd registered.

Femoral Fractures

188 studies on the registry are indexed under Femoral Fractures; 40 are open to participants now.

Browse Femoral Fractures studies →

Open to participants now

6 of the 46 studies in Femoral Fractures with a site in United States are open now. Recruiting first, the newest first:

1 more — sign in →

All 6 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 25 Femoral Fractures studies recruiting now, 14 (56%) set no upper age limit and 2 (8%) stop at 75 or younger; 2 take children under 18; 3 take healthy volunteers.

This study: 60 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 46 studies in Femoral Fractures with a site in United States, or all of them as a file.
02

Study summary

This research study is being conducted to examine the effect of two versus one fixation device for fixation of distal femur fractures.

03

Conditions studied

  • Femur Fracture

Browse trials for

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Femur fracture distal to the femoral diaphysis.
  • Operative treatment within 72 hours of presenting to the treating hospital.
  • Patient was previously ambulatory.
  • Fracture amendable to either single or dual implant fixation.
  • can be obtained from the patient, family member, or power of attorney.

Exclusion criteria

Exclusion Criteria:

  • Associated major lower extremity fracture.
  • Ongoing infection.
  • History of metabolic bone disease (Paget's, etc).
  • Pathologic fracture.
  • Open fracture.
  • Severe cognitive impairment (Six Item Screener with 3 or more errors).
  • Stage 5 Parkinson's disease.
  • Significant femoral bone loss requiring planned staged bone grafting.
  • Vascular injury.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    Single Distal Femur Implant Group

    Subjects will receive one of two types of implants for the distal femur fracture. The single implant will be either a plate and screws or a rod. The type of single implant used will be determined by the surgeon based on the characteristics of the fracture.

    Procedure: Single Distal Femur Implant

  • Experimental
    Dual Distal Femur Implant Group

    Subjects will receive two implants for fixation of the distal femur fracture. The dual implant will be either 2 plates with screws or a plate with screws and a rod. The type of dual implant used will be determined by the surgeon based on the characteristics of the fracture.

    Procedure: Dual Distal Femur Implant

Interventions

  • ProcedureSingle Distal Femur Implant

    Single implant constructs will be either a retrograde intramedullary nail with interlocking screws or a single plate and screw construct.

  • ProcedureDual Distal Femur Implant

    Dual implant constructs will either be an intramedullary nail with an additional plate and screw construct or dual (two plates in any orientation) plate and screw construct.

06

What researchers measure

Primary outcomes

  1. Number of study-eligible subjects

    Total number of subjects to be enrolled in the study

    Time frame: Baseline

Secondary outcomes

  1. Operative times

    Total recorded amount of time in minutes to complete the surgery

    Time frame: Duration of surgery, approximately 2-4 hours

  2. Blood loss

    Total amount of surgical blood loss, reported in mL.

    Time frame: Duration of surgery, approximately 2-4 hours

  3. Hospitalization days

    Total number of days a subject requires hospitalization after surgery

    Time frame: approximately 2-3 days

  4. Early post-surgical complications

    Number of subjects to experience venous thromboembolism (VTE), cardiopulmonary, and/or infectious complications after surgery

    Time frame: 2 weeks post-surgery

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2024 (actual). Primary completion is estimated for Nov 2026, 31 months after the start.

Of 50 non-industry interventional studies with no phase under Femoral Fractures, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 50. This study's planned 31 months is above that.

Counting every sponsor, half of 53 studies reached it within 23 months; a quarter within 9 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 2, 2023
First posted
Sep 11, 2023
StartActual
Apr 29, 2024
Primary completionEst.
Nov 2026
CompletionEst.
Nov 2026
Last update
Mar 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06032299
Lead sponsor
Mayo Clinic
Responsible party
Brandon James Yuan (Principal Investigator, Mayo Clinic) — Principal investigator
First posted
Sep 11, 2023
Start date
Apr 29, 2024
Primary completion
Nov 2026 (estimated)
Completion
Nov 2026 (estimated)
Last update
Mar 10, 2026

Study contacts

Brandon Yuan, MD
principal investigator · Mayo Clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion